Activity

0051 μg·L-1 , 0.016 μg·L-1 , 0.021 μg·L-1 , 0.0056 μg·L-1 , and 0.0062 μg·L-1 , respectively. Recoveries were between 85.60% and 98.42%. These five PAHs in dairy products were determined with good results and therefore expected to be a routine detection method for PAHs in dairy products.The accumulation of toxic carboxylic compounds may cause severe effects on the environment and living organisms. Iclepertin A luciferase-like enzyme, previously cloned from the Malpighian tubules of the non-luminescent Zophobas morio mealworm, displays thioesterification activity with a wide range of carboxylic substrates, and produces weak red luminescence in the presence of ATP and firefly d-luciferin, a xenobiotic for this organism. To better investigate the function of this enzyme in carboxylic xenobiotic detoxification, we analyzed the inhibitory effect of different xenobiotic carboxylic acids on the luminescence activity of this enzyme, including environmental pollutants and pharmaceutical compounds. Noteworthy, the anti-inflammatory drug diclofenac severely inhibited this luciferase-like enzyme luminescence activity, both in in vitro (IC50 20 μM) and in vivo in bacterial cells assays, when compared with other beetle luciferases. Similar results were obtained with its brighter I327S mutant. Kinetic analysis of diclofenac’s effect on luminescence activity indicated mixed-type inhibition for both ATP and d-luciferin. Modelling studies showed five potential binding sites for diclofenac, including the coenzyme A binding site, which showed one of the highest binding constant. Taken together, these results raise the possibility of using this luciferase-like enzyme for the development of novel whole-cell luminescent biosensors for diclofenac and similar drugs.In certain forensic cases, a quantification of direct-acting oral anticoagulants (DOACs) can be necessary. We evaluate the applicability of a previously described liquid chromatography-tandem mass spectrometry (LC-MS/MS) methodology for the determination of DOACs in plasma to postmortem specimen. Postmortem internal quality control (PIQC) samples were prepared in pooled blank postmortem heart blood, femoral blood, cerebrospinal fluid (CSF), and urine as well in plasma. To examine the application of the clinical method to forensic cases, the main validation parameters were reinvestigated using PIQC samples. Postmortem samples of 12 forensic cases with evidence of previous rivaroxaban intake and unknown bleeding disorders were analyzed. Interday variability remained within the acceptance criterion of ±15%. Matrix effects were comparable in blank plasma and postmortem matrix extracts. After 4 weeks of storage in the refrigerator, no relevant decrease of DOACs was evident. After 96 h of storage at room temperature, a slight decrease in edoxaban concentration was observed in CSF and urine, while plasma edoxaban decreased by about 50%. Median (range) rivaroxaban concentrations determined in specimen of forensic cases were as follows heart blood (n = 6), 17.2 ng/ml ( less then LOQ, 56.6 ng/ml); femoral blood (n = 12), 27.6 ng/ml ( less then LOQ, 110.5 ng/ml); CSF (n = 7), 11.7 ng/ml ( less then LOQ, 17.5 ng/ml); urine (n = 6), 275.7 ng/ml (14.5-870.9 ng/ml). The median heart/femoral blood rivaroxaban ratio was 1.2 (n = 5). Exemplary, a forensic case with detection of edoxaban in femoral blood, CSF, and urine, is presented. DOACs can be detected in postmortem heart and femoral blood, CSF, and urine specimen by LC-MS/MS. Based on limited forensic cases, no significant redistribution was evident for rivaroxaban, which was found at highest concentrations in urine.Polymethine cyanine dyes have been widely recognized as promising chemical tools for a range of life science and biomedical applications, such as fluorescent staining of DNA and proteins in gel electrophoresis, fluorescence guided surgery, or as ratiometric probes for probing biochemical pathways. The photophysical properties of such dyes can be tuned through the synthetic modification of the conjugated backbone, for example, by altering aromatic cores or by varying the length of the conjugated polymethine chain. Alternative routes to shaping the absorption, emission, and photostability of dyes of this family are centered around the chemical modifications on the polymethine chain. This Minireview aims to discuss strategies for the introduction of substituents in the meso-position, their effect on the photophysical properties of these dyes and some structure-activity correlations which could help overcome common limitations in the state of the art in the synthesis.The production of hydrogen by water electrolysis benefits from the development of water oxidation catalysts. This development process can be aided by the postulation of design rules for catalytic systems. The analysis of the reactivity of molecular complexes can be complicated by their decomposition under catalytic conditions into nanoparticles that may also be active. Such a misinterpretation can lead to incorrect design rules. In this study, the nickel-based water oxidation catalyst [NiII (meso-L)](ClO4 )2 , which was previously thought to operate as a molecular catalyst, is found to decompose to form a NiOx layer in a pH 7.0 phosphate buffer under prolonged catalytic conditions, as indicated by controlled potential electrolysis, electrochemical quartz crystal microbalance, and X-ray photoelectron spectroscopy measurements. Interestingly, the formed NiOx layer desorbs from the surface of the electrode under less anodic potentials. Therefore, no nickel species can be detected on the electrode after electrolysis. Catalyst decomposition is strongly dependent on the pH and buffer, as there is no indication of NiOx layer formation at pH 6.5 in phosphate buffer nor in a pH 7.0 acetate buffer. Under these conditions, the activity stems from a molecular species, but currents are much lower. This study demonstrates the importance of in situ characterization methods for catalyst decomposition and metal oxide layer formation, and previously proposed design elements for nickel-based catalysts need to be revised.